Eli Lilly and
Scientific Director - AI/ML Antibody Discovery
Eli Lilly and, San Diego, California, United States, 92189
Overview
At Lilly, we unite caring with discovery to make life better for people around the world. We are a global healthcare leader headquartered in Indianapolis, Indiana. Our employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to our communities through philanthropy and volunteerism. We put people first and are looking for people determined to make life better for others. Lilly’s Biotechnology Discovery Research (BioTDR) organization advances novel biotherapeutic medicines into clinical research across therapeutic areas. By combining biology with innovative capabilities in protein discovery, engineering and computational sciences, we are delivering the next wave of biomedicines. We are seeking an accomplished scientific leader to drive the development of next-generation computational platforms for therapeutic antibody discovery. This role will lead the design and implementation of NGS-centric bioinformatics pipelines and machine learning models to accelerate in silico and de novo antibody discovery, directly impacting our large molecule drug discovery pipeline. The ideal candidate brings deep expertise in antibody repertoire sequencing, structural modeling, and ML/AI-driven antibody engineering, along with strong leadership and cross-functional collaboration experience.
#J-18808-Ljbffr
At Lilly, we unite caring with discovery to make life better for people around the world. We are a global healthcare leader headquartered in Indianapolis, Indiana. Our employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to our communities through philanthropy and volunteerism. We put people first and are looking for people determined to make life better for others. Lilly’s Biotechnology Discovery Research (BioTDR) organization advances novel biotherapeutic medicines into clinical research across therapeutic areas. By combining biology with innovative capabilities in protein discovery, engineering and computational sciences, we are delivering the next wave of biomedicines. We are seeking an accomplished scientific leader to drive the development of next-generation computational platforms for therapeutic antibody discovery. This role will lead the design and implementation of NGS-centric bioinformatics pipelines and machine learning models to accelerate in silico and de novo antibody discovery, directly impacting our large molecule drug discovery pipeline. The ideal candidate brings deep expertise in antibody repertoire sequencing, structural modeling, and ML/AI-driven antibody engineering, along with strong leadership and cross-functional collaboration experience.
#J-18808-Ljbffr